References
- Bastien M, Milpied-Homsi B, Baudot S, et al. (1997). Ketoprofen-induced contact photosensitivity disorders: 5 cases. Ann Dermatol Venereol 124:523–6
- Daiichi Sankyo Co., Ltd. (2010). Interview form (product information booklet) of Loxonin® gel 1%. 6th ed. Tokyo, Japan: Daiichi Sankyo Co., Ltd
- Harirforoosh S, Jamali F. (2009). Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf 8:669–81
- Heyneman CA, Lawless-Liday C, Wall GC. (2000). Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs 60:555–74
- Honma M. (1994). Investigation of efficacy and safety in Loxonin® by new post-marketing surveillance. J Clin Ther Med 10:2107–20
- Hotchkiss SAM. (1998). Dermal metabolism. In: Roberts MS, Walter KA, eds. Dermal absorption and toxicity assessment. New York: Marcel Dekker, 43–101
- Kanazawa M, Ito H. (1997). The pharmacokinetics of 0.5% piroxicam gel in humans. Eur J Rheumatol Inflamm 8:117
- Koo TS, Kim DH, Ahn SH, et al (2005). Comparison of pharmacokinetics of loxoprofen and its active metabolites after an intravenous, intramuscular, and oral administration of loxoprofen in rats: evidence for extrahepatic metabolism. J Pharm Sci 94:2187–97
- Koyama K, Takahashi M, Nakai N, et al (2010). Pharmacokinetics and disposition of CS-8958, a long-acting prodrug of the novel neuraminidase inhibitor laninamivir in rats. Xenobiotica 40:207–16
- Kowalzick L, Ziegler H. (2006). Photoallergic contact dermatitis from topical diclofenac in Solaraze gel. Contact Dermatitis 54:348–9
- Lacroix I, Lapeyre-Mestre M, Bagheri H, et al; Club de Reflexion des cabinets de Groupe de Gastro-Enterologie (CREGG); General Practitioner Networks. (2004). Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care. Fundam Clin Pharmacol 18:201–6
- Matsubara T, Arai K, Shiro Y, et al. (2011). Analgestic effects of NSAID gel containing loxoprofen (Loxonin gel 1%) in chronic neck pain females. Pain Clinic 32:715–19
- Matsuda K, Tanaka Y, Ushiyama S, et al. (1984). Inhibition of prostaglandin synthesis by sodium 2-[4-(2-oxocyclopentylmethyl)phenyl] propionate dihydrate (CS-600), a new anti-inflammatory drug, and its active metabolite in vitro and in vivo. Biochem Pharmacol 33:2473–8
- Montoro J, Rodríguez M, Díaz M, Bertomeu F. (2003). Photoallergic contact dermatitis due to diclofenac. Contact Dermatitis 48:115
- Sánchez-Borges M. (2010). NSAID hypersensitivity (respiratory, cutaneous, and generalized anaphylactic symptoms). Med Clin North Am 94:853–64
- Shah AK, Wei G, Lanman RC, et al. (1996). Percutaneous absorption of ketoprofen from different anatomical sites in man. Pharm Res 13:168–72
- Singh G. (2000). Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System. Am J Ther 7:115–21
- Sioufi A, Pommier F, Boschet F, et al. (1994). Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac Emulgel. Biopharm Drug Dispos 15:441–9
- Trommer H, Neubert RH. (2006). Overcoming the stratum corneum: the modulation of skin penetration. A Review. Skin Pharmacol Physiol 19:106–21
- Tsai JC, Cappel MJ, Weiner ND, et al. (1991). Solvent effects on the harvesting of stratum corneum from hairless mouse skin through adhesive tape stripping in vitro. Int J Pharm 68:127–33
- van der Klauw MM, Wilson JH, Stricker BH. (1996). Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974–1994) and review of the literature. Clin Exp Allergy 26:1355–63
- Yamakawa N, Suemasu S, Watanabe H, et al. (2013). Comparison of pharmacokinetics between loxoprofen and its derivative with lower ulcerogenic activity, fluoro-loxoprofen. Drug Metab Pharmacokinet 28:118–24